Odonate(ODTC)
$150,000.000.00 (0.00%)
ODTC
Odonate financials statements
$150,000.00
At close:0.00 (0.00%)
Odonate (ODTC) Ratios
289 Followers
Odonate Ratios
ODTC's free cash flow for Q4 2022 was $5.47M. For the 2022 fiscal year, ODTC's free cash flow was increased by $0.00 and operating cash flow was $5.47M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 111.72 | 82.66 | 4.75 | 5.91 | 7.42 |
| Quick Ratio | 111.72 | 82.66 | 4.75 | 5.91 | 7.42 |
| Cash Ratio | 77.39 | 18.36 | 4.35 | 5.81 | 7.28 |
| Solvency Ratio | 3.15 | 15.01 | -3.41 | -3.95 | -4.20 |
| Operating Cash Flow Ratio | 17.10 | 3.07 | -4.78 | -4.18 | -3.90 |
| Short-Term Operating Cash Flow Coverage | 17.34 | 3.83 | -99.12 | 0.00 | 0.00 |
| Net Current Asset Value | $ 54.76M | $ 45.39M | $ 55.42M | $ 128.13M | $ 157.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.06 | 0.03 | 0.01 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | 0.08 | 0.04 | 0.01 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | 0.07 | 0.04 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.02 | 1.03 | 1.33 | 1.23 | 1.16 |
| Debt Service Coverage Ratio | 14.58 | 92.29 | -88.04 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.14 | 2538.49 | 3340.24 | 4321.84 | 1991.40 |
| Net Debt to EBITDA | -3.94 | -0.80 | 0.95 | 1.21 | 1.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 77.56% | 445.53% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | -1155.94% | -245.93% | 145.90% | 99.15% | 97.30% |
| Return on Assets (ROA) | 6.63% | 41.40% | -86.48% | -75.26% | -59.22% |
| Return on Equity (ROE) | 6.77% | 42.58% | -115.27% | -92.81% | -68.90% |
| Return on Capital Employed (ROCE) | -0.74% | -3.80% | -74.12% | -90.50% | -70.06% |
| Return on Invested Capital (ROIC) | -0.57% | -3.78% | -73.24% | -90.08% | -69.92% |
| Return on Tangible Assets | 6.63% | 41.40% | -86.48% | -75.26% | -59.22% |
| Earnings Yield | 0.01% | 28.13% | -45.27% | -6.68% | -4.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 10.50 | 14.25 | 3.57 | 0.06 | 0.02 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -34.76 | -25.61 | -102.10 | -5944.05 | -14928.60 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 34.76 | 25.61 | 102.10 | 5944.05 | 14928.60 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.14 | 1646.17 | -54197.48 | -91800.54 | -93283.97 |
| Free Cash Flow Per Share | 8.14 | 1646.17 | -54216.09 | -92151.09 | -93444.21 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -2912.50 | -261.88 | -582.16 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -2912.50 | -261.88 | -582.16 |
| Operating Cash Flow Coverage Ratio | 3.80 | 0.65 | -16.23 | -21.24 | -46.84 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | 0.01% | 1.18% | -50.20% | -6.00% | -3.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17599.45 | 3.56 | -2.21 | -14.98 | -24.05 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1192.33 | 1.51 | 2.55 | 13.90 | 16.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14750.11 | 85.05 | -1.99 | -16.67 | -27.78 |
| Price-to-Operating Cash Flow Ratio | 14750.11 | 85.05 | -1.99 | -16.73 | -27.83 |
| Price-to-Earnings Growth (PEG) Ratio | -176.03 | -0.02 | 0.04 | 2.99 | -2.13 |
| Enterprise Value Multiple | 13616.35 | 14.50 | -1.29 | -13.87 | -22.53 |
| Enterprise Value | 128.88B | 144.70M | 86.67M | 1.74B | 2.51B |
| EV to EBITDA | 13616.35 | 14.50 | -1.29 | -13.87 | -22.53 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 14745.85 | 80.61 | -1.14 | -15.33 | -25.94 |
| EV to Operating Cash Flow | 14745.85 | 80.61 | -1.14 | -15.39 | -25.98 |
| Tangible Book Value Per Share | 100.64 | 92487.09 | 42416.10 | 110476.31 | 156667.03 |
| Shareholders’ Equity Per Share | 100.64 | 92487.09 | 42416.10 | 110476.31 | 156667.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | -3.46 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 6.82 | 39379.62 | -48894.03 | -102528.05 | -107943.87 |
| Tax Burden | 0.78 | 4.46 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.19 | 0.04 | 1.11 | 0.90 | 0.86 |
Currency in USD

